Logan Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-210
Closed -$2.24K 409
2025
Q3
$2.24K Hold
210
﹤0.01% 397
2025
Q2
$2.03K Sell
210
-540
-72% -$5.57K ﹤0.01% 396
2025
Q1
$11.2K Hold
750
﹤0.01% 398
2024
Q4
$11.2K Hold
750
﹤0.01% 390
2024
Q3
$14.3K Hold
750
﹤0.01% 389
2024
Q2
$15.5K Sell
750
-29
-4% -$576 ﹤0.01% 382
2024
Q1
$14.6K Sell
779
-156
-17% -$2.68K ﹤0.01% 387
2023
Q4
$13.5K Hold
935
﹤0.01% 401
2023
Q3
$16.2K Hold
935
﹤0.01% 392
2023
Q2
$19.5K Hold
935
﹤0.01% 384
2023
Q1
$22K Hold
935
﹤0.01% 386
2022
Q4
$26.1K Hold
935
﹤0.01% 386
2022
Q3
$22K Sell
935
-4
-0.4% -$121 ﹤0.01% 385
2022
Q2
$32K Sell
939
-10
-1% -$350 ﹤0.01% 376
2022
Q1
$33K Sell
949
-10,035
-91% -$343K ﹤0.01% 383
2021
Q4
$335K Sell
10,984
-797
-7% -$26K 0.01% 270
2021
Q3
$386K Buy
11,781
+11,731
+23,462% +$375K 0.02% 263
2021
Q2
$2K Buy
+50
New +$1.65K ﹤0.01% 506

Other funds holding OGN

Logan Capital Management's OGN Position: Q4 2025 in Review

Logan Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 210 shares — an estimated $2.24K sold.

Logan Capital Management first reported a position in OGN in Q2 2021 and held it in 18 quarters. The position peaked at $386K in Q3 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Logan Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Logan Capital Management sold 210 Organon & Co shares in Q4 2025, an estimated $2.24K.
  • Logan Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 18 quarters.
  • Logan Capital Management's Organon & Co position peaked at $386K in Q3 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Logan Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.